Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalcetrapib in patients hospitalized for ACS
NCT01323153Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of dalcetrapib in acute coronary syndrome (ACS), sponsored by Roche. Started Mar 2011; status: completed.
02
Drugs
dalcetrapib
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01323153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323153.